Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inti Zlobec

Showing results (151-160 of 260) with videos related to

Pageof 26
Sort By:
Plos One|August 18, 2012
Role of KCNMA1 in breast cancerMartin Oeggerli, Yuemin Tian, Christian Ruiz, et al.
American Journal of Clinical Pathology|December 6, 2006
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approachLuigi Tornillo, Alessandro Lugli, Inti Zlobec, et al.
International Journal of Cancer|October 30, 2013
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiencyHeather Dawson, José A Galván, Melina Helbling, et al.
Human Pathology|March 17, 2016
Impact of peritumoral and intratumoral budding in esophageal adenocarcinomasSvenja Thies, Lars Guldener, Julia Slotta-Huspenina, et al.
International Journal of Cancer|February 18, 2010
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancerInti Zlobec, Michal Kovac, Priska Erzberger, et al.
Acta Cytologica|November 4, 2025
Bronchoalveolar Lavage as a Candidate for Artificial Intelligence Integration: Insights into Differential Cell Count and Golde Score Using Conventional Cytology SmearsJosua Schaefer, Fabienne Hagmann, Stefan Reinhard, et al.
The Journal of Pathology. Clinical Research|August 4, 2017
Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experienceViktor H Koelzer, Naziheh Assarzadegan, Heather Dawson, et al.
International Journal of Cancer|October 27, 2009
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patientsDaniel M Frey, Raoul A Droeser, Carsten T Viehl, et al.
Endocrine-Related Cancer|April 13, 2013
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant diseaseTobias Zellweger, Susanne Stürm, Silvia Rey, et al.
Clinical Colorectal Cancer|November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer PatientsJacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Pageof 26

Showing results (151-160 of 260) with videos related to

Sort By:
Pageof 26
Plos One|August 18, 2012
Role of KCNMA1 in breast cancerMartin Oeggerli, Yuemin Tian, Christian Ruiz, et al.
American Journal of Clinical Pathology|December 6, 2006
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approachLuigi Tornillo, Alessandro Lugli, Inti Zlobec, et al.
International Journal of Cancer|October 30, 2013
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiencyHeather Dawson, José A Galván, Melina Helbling, et al.
Human Pathology|March 17, 2016
Impact of peritumoral and intratumoral budding in esophageal adenocarcinomasSvenja Thies, Lars Guldener, Julia Slotta-Huspenina, et al.
International Journal of Cancer|February 18, 2010
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancerInti Zlobec, Michal Kovac, Priska Erzberger, et al.
Acta Cytologica|November 4, 2025
Bronchoalveolar Lavage as a Candidate for Artificial Intelligence Integration: Insights into Differential Cell Count and Golde Score Using Conventional Cytology SmearsJosua Schaefer, Fabienne Hagmann, Stefan Reinhard, et al.
The Journal of Pathology. Clinical Research|August 4, 2017
Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experienceViktor H Koelzer, Naziheh Assarzadegan, Heather Dawson, et al.
International Journal of Cancer|October 27, 2009
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patientsDaniel M Frey, Raoul A Droeser, Carsten T Viehl, et al.
Endocrine-Related Cancer|April 13, 2013
Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant diseaseTobias Zellweger, Susanne Stürm, Silvia Rey, et al.
Clinical Colorectal Cancer|November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer PatientsJacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Pageof 26